Abstract: A dispersion device includes a first dispersion generating system, a second dispersion generating system and an outlet end element including a first outlet corresponding to the first dispersion generating system and a second outlet corresponding to the second dispersion generating system.

Abstract: Systems, apparatuses, and methods to response to distinguish a ghost target from an actual target based on radar signals and ranges determined from the radar signals. In particular, the disclosure provides an intrusion detection system receiving ranges and velocities for targets detected based on radar signals, determining a potential ghost target from the received velocities and confirming the potential ghost target based on estimated ranges and perturbations of the vehicle speed.

Abstract: In an aspect, an intumescent battery pad for a lithium ion battery comprises a polyurethane foam having a compression force deflection of 5 to 1,035 kilopascals at 25% deflection determined in accordance with ASTM D3574-17; and an intumescent material comprising an acid source, a carbon source, and a blowing agent; wherein the intumescent battery pad has a UL-V0 rating at a thickness of 1 millimeter. In another aspect, a battery can comprise at least two battery cells; and an intumescent battery pad located in between the at least two battery cells.

Abstract: The present invention relates to novel compounds that inhibit Lp-PLA2 activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases associated with the activity of Lp-PLA2, for example Alzheimer's disease.

Abstract: The present invention relates to compounds that inhibit at least one of KRas wild type, KRas G12A, KRas G12C, KRas G12D, KRas G12R, KRas G12S, KRas G12V, KRas G13D and KRas Q61H, pharmaceutical compositions comprising the compounds and methods of use therefor.

Abstract: Systems, apparatuses, and methods to response to detected attacks in an autonomous system based on context of the autonomous system are described. In particular, the disclosure provides an intrusion detection system receiving contexts and contracts dictating particular response guide rails from a higher level components or stack on the autonomous system. The intrusion detection system is arranged to respond to attacks according to the contract without intervention by the higher level components or stack.

Abstract: A vehicular camera module includes a main circuit board electrically connected with an imager circuit board having an imager disposed thereat. The vehicular camera module includes a housing having an upper cover and a lower cover that are joined together. Electronic circuitry disposed at a main printed circuit board of the main circuit board includes an image processor. The electronic circuitry disposed at the main printed circuit board of the main circuit board includes an electrical connector configured for electrical connection to a connector of a vehicular wire harness. With the imager operated to capture image data, captured image data is provided via a flexible ribbon cable to the electronic circuitry disposed at the main printed circuit board of the main circuit board. The imager is disposed within a rear portion of the housing and is not accommodated within a front portion of the housing.

Abstract: The present disclosure relates to mTOR inhibitors. Specifically, the embodiments are directed to compounds and compositions inhibiting mTOR, methods of treating diseases mediated by mTOR, and methods of synthesizing these compounds.

Abstract: A method of manufacturing a chip assembly comprises joining an in-process unit to a printed circuit board; reflowing a bonding material disposed between and electrically connecting the in-process unit with the printed circuit board, the bonding material having a first reflow temperature; and then joining a heat distribution device to the plurality of semiconductor chips using a thermal interface material (“TIM”) having a second reflow temperature that is lower than the first reflow temperature. The in-process unit further comprises a substrate having an active surface, a passive surface, and contacts exposed at the active surface; an interposer electrically connected to the substrate; a plurality of semiconductor chips overlying the substrate and electrically connected to the substrate through the interposer, and a stiffener overlying the substrate and having an aperture extending therethrough, the plurality of semiconductor chips being positioned within the aperture.

Abstract: A method of recommending an unplayed game application to a user includes obtaining a game history associated with a user profile, wherein the game history includes at least one game record of a game application the user profile has been used to play, and evaluating the game history to obtain a plurality of game events associated with a game application of the game history. The method further includes accessing a table of tags associated with the plurality of game events associated with the game application, aggregating a plurality of tags in a tag list in the user profile based at least partially on the table of tags and the plurality of game events, and presenting to the user a recommendation of an unplayed game application based at least partially on the plurality of tags.

Abstract: Novel compounds, compositions, and methods of using and preparing the same, which may be useful for treating alpha-1 antitrypsin deficiency (AATD).

Abstract: A component for a vehicle interior may comprise a light guide to allow light transmission from a light source, and a cover to cover the light guide. The light guide may comprise an icon or indicator and the cover may comprise a depression or indentation in an inner surface of the cover. The icon/indicator of the light guide may comprise a light-transmissive resin material configured to fit within the depression/indentation in the cover. The icon/indicator may be presented when illuminated and hidden by the cover when not illuminated. The cover may comprise a polymer material coupled to the light guide. The cover may present a user interface. A surface of the cover may comprise an information region and/or a decorative region. The component may comprise a steering wheel, console, floor console, center console, instrument panel, door panel, dashboard, display, armrest, or cockpit.

Abstract: A method for operating a DRAM device. The method includes receiving in a memory buffer in a first memory module hosted by a computing system, a request for data stored in RAM of the first memory module from a host controller of the computing system. The method includes receiving with the memory buffer, the data associated with a RAM, in response to the request and formatting with the memory buffer, the data into a scrambled data in response to a pseudo-random process. The method includes initiating with the memory buffer, transfer of the scrambled data into an interface device.

Abstract: Methods, systems, and devices for variable density storage device are described. A memory system may receive a write command to write data to the memory system. The memory system may write the data to a first set of memory cells of the memory system using a first write operation based on receiving the write command. The first set of memory cells store three or fewer bits of information in a single memory cell. The memory system may identify whether to transfer the data to a second set of memory cells on one or more parameters associated with the data. The second set of memory cells may store more bits of information in a single memory cell than the first set of memory cells. The memory system may transfer the data to the second set of memory cells based on identifying that the data is to be transferred.

Abstract: Systems and techniques for wireless implantable devices, for example implantable biomedical devices employed for biomodulation. Some embodiments include a biomodulation system including a non-implantable assembly including a source for wireless power transfer and a data communications system, an implantable assembly including a power management module configured to continuously generate one or more operating voltage for the implantable assembly using wireless power transfer from the non-implantable assembly, a control module operably connected to at least one communication channel and at least one stimulation output, the control module including a processor unit to process information sensed via the at least one communication channel and, upon determining a condition exists, to generate an output to trigger the generation of a stimulus.

Abstract: The present invention relates to neutralizing antibodies of the human pituitary adenylate cyclase activating polypeptide type I receptor (PAC1) and pharmaceutical compositions comprising such antibodies. Methods of treating or preventing headache conditions, such as migraine and cluster headache, using the neutralizing antibodies are also described.

Abstract: An embodiment of an integrated circuit may comprise circuitry communicatively coupled to two or more sub-non-uniform memory access clusters (SNCs) to allocate a specified memory space in the two or more SNCs in accordance with a SNC memory allocation policy indicated from a request to initialize the specified memory space. An embodiment of an apparatus may comprise decode circuitry to decode a single instruction, the single instruction to include a field for an opcode, and execution circuitry to execute the decoded instruction according to the opcode to provide an indicated SNC memory allocation policy (e.g., a SNC policy hint). Other embodiments are disclosed and claimed.

Abstract: Antibodies that bind SARS-CoV spike protein, SARS-CoV-2 spike protein, and methods of using same for treating or preventing conditions associated with SARS or COVID-19 and for detecting SARS-CoV or SARS-CoV-2.

Abstract: The present invention relates to the use of hypoxia-inducible factor (HIF) inhibitors in cancer immunotherapy. Specifically, the disclosure provides methods of treating a cancer in a subject in need of cancer immunotherapy, comprising administering a HIF-1a inhibitor to the subject and a second cancer immunotherapeutic agent to the subject, wherein the HIF-1a inhibitor comprising echinomycin, and wherein the second cancer immunotherapeutic agent comprising an anti-CTLA-4 antibody including Ipilimumab or Tremelimumab.